Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	cell surface	NRCAM HLA-A AXL CFTR SLITRK3 SIRPB1 SIRPA BTN3A2 SLC2A4 GHR BTN3A3 FCGR1A PROM2 VCAN CSPG4 LRP2 HTR3B CCL19 LILRB5	9.67e-05	1111	135	19	GO:0009986
MousePheno	absent anterior visceral endoderm	CHD1 INO80 MED12	1.25e-05	7	101	3	MP:0012159
Domain	NUT	NUTM2A NUTM2G NUTM2B NUTM2F	1.22e-08	5	133	4	IPR024310
Domain	NUT_N	NUTM2A NUTM2G NUTM2B NUTM2F	1.22e-08	5	133	4	IPR024309
Domain	NUT	NUTM2A NUTM2G NUTM2B NUTM2F	1.22e-08	5	133	4	PF12881
Domain	-	COL7A1 MYLK NRCAM HLA-A AXL SIRPB1 SIRPA BTN3A2 SEMA4G GHR BTN3A3 FCGR1A VCAN KIR2DL5A IGSF9 SIGLEC1 USH2A TNXB LILRB5 PLXNB1	4.85e-08	663	133	20	2.60.40.10
Domain	Ig-like_fold	COL7A1 MYLK NRCAM HLA-A AXL SIRPB1 SIRPA BTN3A2 SEMA4G GHR BTN3A3 FCGR1A VCAN KIR2DL5A IGSF9 SIGLEC1 USH2A TNXB LILRB5 PLXNB1	1.35e-07	706	133	20	IPR013783
Domain	LAM_G_DOMAIN	CNTNAP3B FAT4 CNTNAP3 CSPG4 USH2A CRB2	2.67e-07	38	133	6	PS50025
Domain	EGF_1	CNTNAP3B FAT4 CLEC18B CNTNAP3 CLEC18C VWCE ATRAID VCAN LRP2 USH2A TNXB CRB2	2.88e-07	255	133	12	PS00022
Domain	Laminin_G_2	CNTNAP3B FAT4 CNTNAP3 CSPG4 USH2A CRB2	3.66e-07	40	133	6	PF02210
Domain	LamG	CNTNAP3B FAT4 CNTNAP3 CSPG4 USH2A CRB2	6.58e-07	44	133	6	SM00282
Domain	EGF	CNTNAP3B FAT4 CLEC18B CNTNAP3 CLEC18C VWCE ATRAID VCAN LRP2 TNXB CRB2	9.71e-07	235	133	11	SM00181
Domain	EGF_3	CNTNAP3B FAT4 CLEC18B CNTNAP3 CLEC18C VWCE ATRAID VCAN LRP2 TNXB CRB2	9.71e-07	235	133	11	PS50026
Domain	EGF-like_dom	CNTNAP3B FAT4 CLEC18B CNTNAP3 CLEC18C VWCE ATRAID VCAN LRP2 TNXB CRB2	1.71e-06	249	133	11	IPR000742
Domain	IG	MYLK NRCAM AXL SIRPB1 SIRPA BTN3A2 SEMA4G BTN3A3 FCGR1A VCAN KIR2DL5A IGSF9 SIGLEC1 LILRB5	1.88e-06	421	133	14	SM00409
Domain	Ig_sub	MYLK NRCAM AXL SIRPB1 SIRPA BTN3A2 SEMA4G BTN3A3 FCGR1A VCAN KIR2DL5A IGSF9 SIGLEC1 LILRB5	1.88e-06	421	133	14	IPR003599
Domain	IG_LIKE	MYLK NRCAM HLA-A AXL SIRPB1 SIRPA BTN3A2 SEMA4G BTN3A3 FCGR1A VCAN KIR2DL5A IGSF9 SIGLEC1 LILRB5	2.26e-06	491	133	15	PS50835
Domain	Ig-like_dom	MYLK NRCAM HLA-A AXL SIRPB1 SIRPA BTN3A2 SEMA4G BTN3A3 FCGR1A VCAN KIR2DL5A IGSF9 SIGLEC1 LILRB5	3.04e-06	503	133	15	IPR007110
Domain	EGF_2	CNTNAP3B FAT4 CLEC18B CNTNAP3 CLEC18C VWCE ATRAID VCAN LRP2 TNXB CRB2	3.12e-06	265	133	11	PS01186
Domain	Laminin_G	CNTNAP3B FAT4 CNTNAP3 CSPG4 USH2A CRB2	3.48e-06	58	133	6	IPR001791
Domain	EGF-like_CS	FAT4 CLEC18B CNTNAP3 CLEC18C VWCE ATRAID VCAN LRP2 TNXB CRB2	1.79e-05	261	133	10	IPR013032
Domain	fn3	COL7A1 MYLK NRCAM AXL GHR IGSF9 USH2A TNXB	2.11e-05	162	133	8	PF00041
Domain	ConA-like_dom	CNTNAP3B FAT4 TRIM58 CNTNAP3 BTN3A3 NBEAL2 CSPG4 USH2A CRB2	2.75e-05	219	133	9	IPR013320
Domain	PH_13	ITSN1 ITSN2	5.03e-05	2	133	2	PF16652
Domain	FN3	COL7A1 MYLK NRCAM AXL GHR IGSF9 USH2A TNXB	5.44e-05	185	133	8	SM00060
Domain	SNF2_N	CHD1 CHD3 CHD4 INO80	7.57e-05	32	133	4	IPR000330
Domain	SNF2_N	CHD1 CHD3 CHD4 INO80	7.57e-05	32	133	4	PF00176
Domain	FN3	COL7A1 MYLK NRCAM AXL GHR IGSF9 USH2A TNXB	9.07e-05	199	133	8	PS50853
Domain	FN3_dom	COL7A1 MYLK NRCAM AXL GHR IGSF9 USH2A TNXB	1.27e-04	209	133	8	IPR003961
Domain	CHD_N	CHD3 CHD4	1.50e-04	3	133	2	IPR012958
Domain	CHD_C2	CHD3 CHD4	1.50e-04	3	133	2	IPR012957
Domain	CHDCT2	CHD3 CHD4	1.50e-04	3	133	2	PF08074
Domain	CHDNT	CHD3 CHD4	1.50e-04	3	133	2	PF08073
Domain	DUF1086	CHD3 CHD4	1.50e-04	3	133	2	IPR009462
Domain	DUF1087	CHD3 CHD4	1.50e-04	3	133	2	IPR009463
Domain	DUF1087	CHD3 CHD4	1.50e-04	3	133	2	PF06465
Domain	DUF1086	CHD3 CHD4	1.50e-04	3	133	2	PF06461
Domain	DUF1087	CHD3 CHD4	1.50e-04	3	133	2	SM01147
Domain	DUF1086	CHD3 CHD4	1.50e-04	3	133	2	SM01146
Domain	V-set	AXL SIRPB1 SIRPA BTN3A2 BTN3A3 VCAN SIGLEC1	3.52e-04	184	133	7	PF07686
Domain	Ig_V-set	AXL SIRPB1 SIRPA BTN3A2 BTN3A3 VCAN SIGLEC1	5.63e-04	199	133	7	IPR013106
Domain	-	FAT4 CNTNAP3 CSPG4 USH2A CRB2	5.89e-04	95	133	5	2.60.120.200
Domain	Chromo_domain	CHD1 CHD3 CHD4	6.40e-04	24	133	3	IPR023780
Domain	EGF_Ca-bd_CS	FAT4 VWCE VCAN LRP2 CRB2	6.48e-04	97	133	5	IPR018097
Domain	EGF_CA	FAT4 VWCE VCAN LRP2 CRB2	7.11e-04	99	133	5	PS01187
Domain	Adcy_conserved_dom	ADCY2 ADCY8	7.41e-04	6	133	2	IPR009398
Domain	DUF1053	ADCY2 ADCY8	7.41e-04	6	133	2	PF06327
Domain	ASX_HYDROXYL	FAT4 VWCE VCAN LRP2 CRB2	7.44e-04	100	133	5	PS00010
Domain	Chromo	CHD1 CHD3 CHD4	8.14e-04	26	133	3	PF00385
Domain	EGF-type_Asp/Asn_hydroxyl_site	FAT4 VWCE VCAN LRP2 CRB2	9.68e-04	106	133	5	IPR000152
Domain	CHROMO_1	CHD1 CHD3 CHD4	1.02e-03	28	133	3	PS00598
Domain	CHROMO_2	CHD1 CHD3 CHD4	1.02e-03	28	133	3	PS50013
Domain	TLV_coat	ERVS71-1 ERVFRD-1	1.03e-03	7	133	2	PF00429
Domain	AC_N	ADCY2 ADCY8	1.37e-03	8	133	2	IPR032628
Domain	Adcy	ADCY2 ADCY8	1.37e-03	8	133	2	IPR030672
Domain	TLV/ENV_coat_polyprotein	ERVS71-1 ERVFRD-1	1.37e-03	8	133	2	IPR018154
Domain	AC_N	ADCY2 ADCY8	1.37e-03	8	133	2	PF16214
Domain	FIBRINOGEN_C_1	CNTNAP3B CNTNAP3 TNXB	1.51e-03	32	133	3	PS00514
Domain	Fibrinogen_a/b/g_C_dom	CNTNAP3B CNTNAP3 TNXB	1.51e-03	32	133	3	IPR002181
Domain	FIBRINOGEN_C_2	CNTNAP3B CNTNAP3 TNXB	1.51e-03	32	133	3	PS51406
Domain	Chromodomain-like	CHD1 CHD3 CHD4	1.51e-03	32	133	3	IPR016197
Domain	Chromo/shadow_dom	CHD1 CHD3 CHD4	1.65e-03	33	133	3	IPR000953
Domain	CHROMO	CHD1 CHD3 CHD4	1.65e-03	33	133	3	SM00298
Domain	EGF_CA	FAT4 VWCE VCAN LRP2 CRB2	1.81e-03	122	133	5	SM00179
Domain	EGF-like_Ca-bd_dom	FAT4 VWCE VCAN LRP2 CRB2	1.94e-03	124	133	5	IPR001881
Domain	DNA/RNA_helicase_DEAH_CS	CHD1 CHD3 CHD4	1.96e-03	35	133	3	IPR002464
Domain	IGv	SIRPB1 SIRPA BTN3A2 BTN3A3	2.02e-03	75	133	4	SM00406
Domain	EGF	CNTNAP3 VCAN LRP2 TNXB CRB2	2.08e-03	126	133	5	PF00008
Domain	EF-hand_4	ITSN1 ITSN2	2.18e-03	10	133	2	PF12763
Domain	ig	NRCAM AXL FCGR1A KIR2DL5A SIGLEC1 LILRB5	2.42e-03	190	133	6	PF00047
Domain	Immunoglobulin	NRCAM AXL FCGR1A KIR2DL5A SIGLEC1 LILRB5	2.42e-03	190	133	6	IPR013151
Domain	DEAH_ATP_HELICASE	CHD1 CHD3 CHD4	2.48e-03	38	133	3	PS00690
Domain	EH	ITSN1 ITSN2	2.65e-03	11	133	2	PS50031
Domain	EH	ITSN1 ITSN2	2.65e-03	11	133	2	SM00027
Domain	EH_dom	ITSN1 ITSN2	2.65e-03	11	133	2	IPR000261
Domain	C-type_lectin_CS	CLEC18B CLEC18C VCAN	3.54e-03	43	133	3	IPR018378
Domain	CAP	CLEC18B CLEC18C	4.97e-03	15	133	2	PF00188
Domain	SCP	CLEC18B CLEC18C	4.97e-03	15	133	2	SM00198
Domain	Allrgn_V5/Tpx1	CLEC18B CLEC18C	4.97e-03	15	133	2	IPR001283
Domain	-	CLEC18B CLEC18C	4.97e-03	15	133	2	3.40.33.10
Domain	CAP_domain	CLEC18B CLEC18C	4.97e-03	15	133	2	IPR014044
Domain	A/G_cyclase_CS	ADCY2 ADCY8	6.38e-03	17	133	2	IPR018297
Domain	C1-set	HLA-A SIRPB1 SIRPA	6.72e-03	54	133	3	PF07654
Domain	IGc2	MYLK NRCAM FCGR1A IGSF9 SIGLEC1 LILRB5	6.78e-03	235	133	6	SM00408
Domain	Ig_sub2	MYLK NRCAM FCGR1A IGSF9 SIGLEC1 LILRB5	6.78e-03	235	133	6	IPR003598
Pubmed	Characterization of the CHD family of proteins.	CHD1 CHD3 CHD4	2.66e-07	4	142	3	9326634
Pubmed	Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association.	SIRPB1 SIRPA GHR	2.30e-06	7	142	3	9507023
Pubmed	The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	CLPSL2 CLEC18B DBF4B PRADC1 PIGU CDAN1 SPCS3 CBLN4 ZDHHC24 PROM2 ATRAID NBEAL2 GBGT1 IGSF9 SERPINA10 ERVFRD-1	2.95e-06	985	142	16	12975309
Pubmed	Mammalian chromodomain proteins: their role in genome organisation and expression.	CHD1 CHD3 CHD4	3.68e-06	8	142	3	10655032
Pubmed	Protein tyrosine phosphatase SHP-1 positively regulates TLR-induced IL-12p40 production in macrophages through inhibition of phosphatidylinositol 3-kinase.	SIRPB1 SIRPA LILRB5	1.07e-05	11	142	3	20145200
Pubmed	Common variants on chromosome 6p22.1 are associated with schizophrenia.	PRSS16 POM121L2 BTN3A2	1.07e-05	11	142	3	19571809
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	NRCAM SIRPB1 SIRPA CSPG4 SERPINA10 TNXB LILRB5 PLXNB1	1.14e-05	257	142	8	16335952
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	DMXL2 TMC6 USP24 XBP1 NUTM2D ARHGAP17 UFL1 RFTN2 ADCY2 NUTM2G NUTM2E NUTM2B NBEAL2 DHCR24 SNAPC4 NUTM2F CRB2	1.35e-05	1242	142	17	30973865
Pubmed	Analysis of axonal regeneration in the central and peripheral nervous systems of the NG2-deficient mouse.	VCAN CSPG4	1.66e-05	2	142	2	17900358
Pubmed	Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen.	CHD3 CHD4	1.66e-05	2	142	2	7560064
Pubmed	Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.	VCAN CSPG4	1.66e-05	2	142	2	15609081
Pubmed	Intersectin deficiency impairs cortico-striatal neurotransmission and causes obsessive-compulsive behaviors in mice.	ITSN1 ITSN2	1.66e-05	2	142	2	37603735
Pubmed	Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B.	KIR2DL5B KIR2DL5A	1.66e-05	2	142	2	12185535
Pubmed	Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene.	KIR2DL5B KIR2DL5A	1.66e-05	2	142	2	11086080
Pubmed	Different chromosomal localization of two adenylyl cyclase genes expressed in human brain.	ADCY2 ADCY8	1.66e-05	2	142	2	1427768
Pubmed	Exon Inclusion Modulates Conformational Plasticity and Autoinhibition of the Intersectin 1 SH3A Domain.	ITSN1 ITSN2	1.66e-05	2	142	2	31031201
Pubmed	Intersectin associates with synapsin and regulates its nanoscale localization and function.	ITSN1 ITSN2	1.66e-05	2	142	2	29078407
Pubmed	The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation.	CHD3 CHD4	1.66e-05	2	142	2	7575689
Pubmed	Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task.	CNTNAP3B CNTNAP3	1.66e-05	2	142	2	26807827
Pubmed	SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion.	CFTR SLC6A14	1.66e-05	2	142	2	30004386
Pubmed	CD169 and CD64 could help differentiate bacterial from CoVID-19 or other viral infections in the Emergency Department.	FCGR1A SIGLEC1	1.66e-05	2	142	2	33491921
Pubmed	Vertebrate intersectin1 is repurposed to facilitate cortical midline connectivity and higher order cognition.	ITSN1 ITSN2	1.66e-05	2	142	2	23447614
Pubmed	Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4.	KIR2DL5B KIR2DL5A	1.66e-05	2	142	2	17215859
Pubmed	The human intersectin genes and their spliced variants are differentially expressed.	ITSN1 ITSN2	1.66e-05	2	142	2	11690630
Pubmed	Effect of an acute long-duration exercise bout on skeletal muscle lipid droplet morphology, GLUT 4 protein, and perilipin protein expression.	SLC2A4 PLIN1	1.66e-05	2	142	2	37368137
Pubmed	The critical role of ASD-related gene CNTNAP3 in regulating synaptic development and social behavior in mice.	CNTNAP3B CNTNAP3	1.66e-05	2	142	2	31150793
Pubmed	Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo.	MYLK CFTR	1.66e-05	2	142	2	16184195
Pubmed	Adaptor proteins intersectin 1 and 2 bind similar proline-rich ligands but are differentially recognized by SH2 domain-containing proteins.	ITSN1 ITSN2	1.66e-05	2	142	2	23936226
Pubmed	Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development.	CHD3 CHD4	1.66e-05	2	142	2	35568926
Pubmed	Immunohistochemical study of NG2 chondroitin sulfate proteoglycan expression in the small and large intestines.	VCAN CSPG4	1.66e-05	2	142	2	16625365
Pubmed	Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen.	CHD3 CHD4	1.66e-05	2	142	2	8843877
Pubmed	Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease.	BTN3A2 FOCAD GHR CSPG4 TNXB	1.76e-05	78	142	5	19204726
Pubmed	Molecular characterization of the ankle-link complex in cochlear hair cells and its role in the hair bundle functioning.	ADCY2 ADCY8 USH2A	3.59e-05	16	142	3	17567809
Pubmed	Spatiotemporal gene expression patterns reveal molecular relatedness between retinal laminae.	SIRPB1 SIRPA RUNDC3A CSPG4	4.89e-05	49	142	4	31609468
Pubmed	SIRPα maintains macrophage homeostasis by interacting with PTK2B kinase in Mycobacterium tuberculosis infection and through autophagy and necroptosis.	SIRPB1 SIRPA	4.95e-05	3	142	2	36202053
Pubmed	Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the migration of Langerhans cells from the epidermis to draining lymph nodes.	SIRPB1 SIRPA	4.95e-05	3	142	2	15034021
Pubmed	Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity.	CLEC18B CLEC18C	4.95e-05	3	142	2	26170455
Pubmed	Behavioral analysis in mice deficient for GAREM2 (Grb2-associated regulator of Erk/MAPK subtype2) that is a subtype of highly expressing in the brain.	ITSN1 ITSN2	4.95e-05	3	142	2	31718706
Pubmed	Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha.	SIRPB1 SIRPA	4.95e-05	3	142	2	34917090
Pubmed	Inhibitory regulation of osteoclast bone resorption by signal regulatory protein alpha.	SIRPB1 SIRPA	4.95e-05	3	142	2	19667119
Pubmed	SIRPA-Inhibited, Marrow-Derived Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid Tumors.	SIRPB1 SIRPA	4.95e-05	3	142	2	28669759
Pubmed	Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus.	SIRPB1 SIRPA	4.95e-05	3	142	2	12134038
Pubmed	Central nervous system antigen P84 can serve as a substrate for neurite outgrowth.	SIRPB1 SIRPA	4.95e-05	3	142	2	2303162
Pubmed	SHPS-1 promotes the survival of circulating erythrocytes through inhibition of phagocytosis by splenic macrophages.	SIRPB1 SIRPA	4.95e-05	3	142	2	16141346
Pubmed	A role for SHPS-1/SIRPalpha in Concanavalin A-dependent production of MMP-9.	SIRPB1 SIRPA	4.95e-05	3	142	2	17825046
Pubmed	SIRPα deficiency accelerates the pathologic process in models of Parkinson disease.	SIRPB1 SIRPA	4.95e-05	3	142	2	31322787
Pubmed	The Rho kinase pathway regulates the migration of dendritic cells through SIRP-α.	SIRPB1 SIRPA	4.95e-05	3	142	2	22391241
Pubmed	Intersectin 2, a new multimodular protein involved in clathrin-mediated endocytosis.	ITSN1 ITSN2	4.95e-05	3	142	2	10922467
Pubmed	Expression of recipient CD47 on rat insulinoma cell xenografts prevents macrophage-mediated rejection through SIRPα inhibitory signaling in mice.	SIRPB1 SIRPA	4.95e-05	3	142	2	23472187
Pubmed	SIRP/CD47 signaling in neurological disorders.	SIRPB1 SIRPA	4.95e-05	3	142	2	25795378
Pubmed	Deficiency in SIRP-α cytoplasmic recruitment confers protection from acute kidney injury.	SIRPB1 SIRPA	4.95e-05	3	142	2	31370677
Pubmed	A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression.	SIRPB1 SIRPA	4.95e-05	3	142	2	30770827
Pubmed	Signal regulatory protein α protects podocytes through promoting autophagic activity.	SIRPB1 SIRPA	4.95e-05	3	142	2	30888336
Pubmed	Podocyte SIRPα reduction aggravates lupus nephritis via promoting T cell inflammatory responses.	SIRPB1 SIRPA	4.95e-05	3	142	2	38758648
Pubmed	Requirement of SIRPα for protective immunity against Leishmania major.	SIRPB1 SIRPA	4.95e-05	3	142	2	20854790
Pubmed	BIT, an immune antigen receptor-like molecule in the brain.	SIRPB1 SIRPA	4.95e-05	3	142	2	9271230
Pubmed	Gene structure of mouse BIT/SHPS-1.	SIRPB1 SIRPA	4.95e-05	3	142	2	10585853
Pubmed	Expression of Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 in pancreatic beta-Cells and its role in promotion of insulin secretion and protection against diabetes.	SIRPB1 SIRPA	4.95e-05	3	142	2	18635660
Pubmed	The chromatin-remodeling enzyme CHD3 plays a role in embryonic viability but is dispensable for early vascular development.	CHD3 CHD4	4.95e-05	3	142	2	32658897
Pubmed	Resistance to collagen-induced arthritis in SHPS-1 mutant mice.	SIRPB1 SIRPA	4.95e-05	3	142	2	18455510
Pubmed	Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function.	SIRPB1 SIRPA	4.95e-05	3	142	2	19223164
Pubmed	Endothelial SIRPα signaling controls VE-cadherin endocytosis for thymic homing of progenitor cells.	SIRPB1 SIRPA	4.95e-05	3	142	2	35511221
Pubmed	The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney.	NUTM2E NUTM2B	4.95e-05	3	142	2	26542179
Pubmed	Focal cerebral ischemia upregulates SHP-1 in reactive astrocytes in juvenile mice.	SIRPB1 SIRPA	4.95e-05	3	142	2	12742627
Pubmed	Dendritic cell SIRPα regulates homeostasis of dendritic cells in lymphoid organs.	SIRPB1 SIRPA	4.95e-05	3	142	2	25818708
Pubmed	XBP1 regulates the protumoral function of tumor-associated macrophages in human colorectal cancer.	XBP1 SIRPA	4.95e-05	3	142	2	34667145
Pubmed	PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse.	VCAN CSPG4	4.95e-05	3	142	2	10036240
Pubmed	Non-Hematopoietic and Hematopoietic SIRPα Signaling Differently Regulates Murine B Cell Maturation in Bone Marrow and Spleen.	SIRPB1 SIRPA	4.95e-05	3	142	2	26222253
Pubmed	Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1.	SIRPB1 SIRPA	4.95e-05	3	142	2	12167615
Pubmed	Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk.	SIRPB1 SIRPA	4.95e-05	3	142	2	31507080
Pubmed	The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.	NUTM2A NUTM2B	4.95e-05	3	142	2	22456610
Pubmed	Involvement of signal regulatory protein α, a negative regulator of Toll-like receptor signaling, in impairing the MyD88-independent pathway and intracellular killing of Burkholderia pseudomallei-infected mouse macrophages.	SIRPB1 SIRPA	4.95e-05	3	142	2	22988019
Pubmed	Hypothermia-induced tyrosine phosphorylation of SIRPα in the brain.	SIRPB1 SIRPA	4.95e-05	3	142	2	22468987
Pubmed	Effect of Serum Deprivation Stress on Signal Induction Regulatory Protein-Alpha (SIRP-Alpha)-Mediated Erythrophagocytosis by Macrophages.	SIRPB1 SIRPA	4.95e-05	3	142	2	30894504
Pubmed	SIRPα controls the activity of the phagocyte NADPH oxidase by restricting the expression of gp91(phox).	SIRPB1 SIRPA	4.95e-05	3	142	2	23022485
Pubmed	Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity.	SIRPB1 SIRPA	4.95e-05	3	142	2	29158380
Pubmed	Lack of non-hematopoietic SIRPα signaling disturbs the splenic marginal zone architecture resulting in accumulation and displacement of marginal zone B cells.	SIRPB1 SIRPA	4.95e-05	3	142	2	25817792
Pubmed	Deletion of SIRPα (signal regulatory protein-α) promotes phagocytic clearance of myelin debris in Wallerian degeneration, axon regeneration, and recovery from nerve injury.	SIRPB1 SIRPA	4.95e-05	3	142	2	31883525
Pubmed	Signal regulatory protein α is associated with tumor-polarized macrophages phenotype switch and plays a pivotal role in tumor progression.	SIRPB1 SIRPA	4.95e-05	3	142	2	23504854
Pubmed	SIRPα signaling regulates podocyte structure and function.	SIRPB1 SIRPA	4.95e-05	3	142	2	23842779
Pubmed	Essential roles of SIRPα in homeostatic regulation of skin dendritic cells.	SIRPB1 SIRPA	4.95e-05	3	142	2	20955735
Pubmed	Soluble SIRP-Alpha Promotes Murine Acute Lung Injury Through Suppressing Macrophage Phagocytosis.	SIRPB1 SIRPA	4.95e-05	3	142	2	35634325
Pubmed	The murine P84 neural adhesion molecule is SHPS-1, a member of the phosphatase-binding protein family.	SIRPB1 SIRPA	4.95e-05	3	142	2	9348339
Pubmed	Targeting SIRP-α protects from type 2-driven allergic airway inflammation.	SIRPB1 SIRPA	4.95e-05	3	142	2	21108471
Pubmed	Mutational analysis of the mechanism of negative regulation by SRC homology 2 domain-containing protein tyrosine phosphatase substrate-1 of phagocytosis in macrophages.	SIRPB1 SIRPA	4.95e-05	3	142	2	16920950
Pubmed	Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the induction of Langerhans cell maturation.	SIRPB1 SIRPA	4.95e-05	3	142	2	17109464
Pubmed	Signal regulatory protein α negatively regulates mast-cell activation following FcεRI aggregation.	SIRPB1 SIRPA	4.95e-05	3	142	2	23504624
Pubmed	Signal regulatory protein alpha (SIRPα) regulates the homeostasis of CD103(+) CD11b(+) DCs in the intestinal lamina propria.	SIRPB1 SIRPA	4.95e-05	3	142	2	25236797
Pubmed	Radioligand binding analysis of knockout mice reveals 5-hydroxytryptamine(7) receptor distribution and uncovers 8-hydroxy-2-(di-n-propylamino)tetralin interaction with alpha(2) adrenergic receptors.	HTR7 ADRA2C	4.95e-05	3	142	2	15026130
Pubmed	Loss of microglial SIRPα promotes synaptic pruning in preclinical models of neurodegeneration.	SIRPB1 SIRPA	4.95e-05	3	142	2	33795678
Pubmed	Resistance to experimental autoimmune encephalomyelitis and impaired T cell priming by dendritic cells in Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 mutant mice.	SIRPB1 SIRPA	4.95e-05	3	142	2	17617577
Pubmed	Tyrosine phosphorylation of the transmembrane protein SIRPα: Sensing synaptic activity and regulating ectodomain cleavage for synapse maturation.	SIRPB1 SIRPA	4.95e-05	3	142	2	29914984
Pubmed	SHPS-1 regulates integrin-mediated cytoskeletal reorganization and cell motility.	SIRPB1 SIRPA	4.95e-05	3	142	2	11118207
Pubmed	Intratumoral SIRPα-deficient macrophages activate tumor antigen-specific cytotoxic T cells under radiotherapy.	SIRPB1 SIRPA	4.95e-05	3	142	2	34050181
Pubmed	Ectodomain shedding of SHPS-1 and its role in regulation of cell migration.	SIRPB1 SIRPA	4.95e-05	3	142	2	15123722
Pubmed	SIRPα+ dendritic cells promote the development of fibroblastic reticular cells in murine peripheral lymph nodes.	SIRPB1 SIRPA	4.95e-05	3	142	2	31099900
Pubmed	Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance.	SIRPB1 SIRPA	4.95e-05	3	142	2	33074246
Pubmed	Promoter variants of KIR2DL5 add to diversity and may impact gene expression.	KIR2DL5B KIR2DL5A	4.95e-05	3	142	2	18461314
Pubmed	The C-type lectin-like domain superfamily.	CLEC18B CLEC18C	4.95e-05	3	142	2	16336259
Pubmed	Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset.	BTN3A2 BTN3A3	4.95e-05	3	142	2	22767497
GeneFamily	Fibronectin type III domain containing	COL7A1 MYLK NRCAM AXL GHR IGSF9 USH2A TNXB	1.44e-06	160	91	8	555
GeneFamily	Adenosine receptors\|V-set domain containing	AXL SIRPB1 SIRPA BTN3A2 BTN3A3 VCAN SIGLEC1	1.82e-05	163	91	7	590
GeneFamily	CD molecules\|V-set domain containing\|C1-set domain containing\|Signal regulatory proteins	SIRPB1 SIRPA	2.48e-04	5	91	2	747
GeneFamily	Adenylate cyclases\|Deafness associated genes	ADCY2 ADCY8	1.10e-03	10	91	2	53
GeneFamily	C1-set domain containing	HLA-A SIRPB1 SIRPA	1.23e-03	42	91	3	591
GeneFamily	PHD finger proteins\|NuRD complex	CHD3 CHD4	1.60e-03	12	91	2	1305
GeneFamily	Butyrophilins\|V-set domain containing\|C2-set domain containing	BTN3A2 BTN3A3	2.52e-03	15	91	2	458
GeneFamily	Immunoglobulin like domain containing	NRCAM AXL SEMA4G FCGR1A IGSF9	2.92e-03	193	91	5	594
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DL5B KIR2DL5A	3.64e-03	18	91	2	620
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ITSN1 PLEKHG2 ITSN2	4.49e-03	66	91	3	722
CoexpressionAtlas	Myeloid Cells, MF.Lu, CD11chi CD11b- CD103- MHCII- SiglecF+, Lung, avg-3	DMXL2 AXL SIRPB1 SIRPA SIGLEC1 TNFAIP2	1.05e-05	83	127	6	GSM538282_100
ToppCell	(6)_Macrophage\|World / shred on Cell_type and subtype	DMXL2 AXL SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2 LILRB5	2.02e-07	197	139	8	010b275d4da4a896175ad7fbaa96d1dc11a0b744
ToppCell	Transverse-(6)_Macrophage\|Transverse / shred on region, Cell_type, and subtype	DMXL2 AXL SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2 LILRB5	2.27e-07	200	139	8	b28350de555fa756d2631f004f71d5ac69b1affe
ToppCell	Caecum-Macrophage-Macrophage\|Caecum / Region, Cell class and subclass	DMXL2 AXL SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 LILRB5	2.27e-07	200	139	8	99dcf07b17ecf90d596f3b8a12d5b7aae2a351d5
ToppCell	mLN-(6)_Macrophage-(61)_LYVE1_Macrophage\|mLN / shred on region, Cell_type, and subtype	DMXL2 ITSN1 FFAR4 FCGR1A VCAN SIGLEC1 TNFAIP2 LILRB5	2.27e-07	200	139	8	a20f5ec61d492d8a2adf695ec304b5d57296aa8f
ToppCell	mLN-Macrophage-LYVE1_Macrophage\|mLN / Region, Cell class and subclass	DMXL2 ITSN1 FFAR4 FCGR1A VCAN SIGLEC1 TNFAIP2 LILRB5	2.27e-07	200	139	8	89cf739a3c2f5d30e547404f2f2ec6500cd1d65d
ToppCell	Transverse-Macrophage\|Transverse / Region, Cell class and subclass	DMXL2 AXL SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2 LILRB5	2.27e-07	200	139	8	1920605e5811938814d02b971069a4506868db5f
ToppCell	Sigmoid-Macrophage\|Sigmoid / Region, Cell class and subclass	DMXL2 AXL SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2 LILRB5	2.27e-07	200	139	8	b07ac0ff3b8530e99094678fed80f35949cafac8
ToppCell	Caecum-(6)_Macrophage-(60)_Macrophage\|Caecum / shred on region, Cell_type, and subtype	DMXL2 AXL SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 LILRB5	2.27e-07	200	139	8	67b6cdeb07ffc5c9af7a3e738dd31256cf391e98
ToppCell	Caecum-(6)_Macrophage\|Caecum / shred on region, Cell_type, and subtype	DMXL2 AXL SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 LILRB5	2.27e-07	200	139	8	2ce3930645c3daf6be578f7881e57a58df61e75c
ToppCell	mild-Classical_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DMXL2 SIRPB1 SIRPA PLEKHG2 FCGR1A VCAN SIGLEC1 TNFAIP2	2.27e-07	200	139	8	c8b80d4e7f70c66cbbdd0665821bcd5db69c7d35
ToppCell	Caecum-Macrophage\|Caecum / Region, Cell class and subclass	DMXL2 AXL SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 LILRB5	2.27e-07	200	139	8	d83209559187a4419df2508ecc5eb9f7d72fced3
ToppCell	Sigmoid-(6)_Macrophage\|Sigmoid / shred on region, Cell_type, and subtype	DMXL2 AXL SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2 LILRB5	2.27e-07	200	139	8	9e10cca4429de2c4c8c3c6cf2c9e28637a095be9
ToppCell	(60)_Macrophage\|World / shred on Cell_type and subtype	DMXL2 AXL SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2 LILRB5	2.64e-07	204	139	8	06d0cb306f1ad0014d81f8228868938e48c2bcf3
ToppCell	3'-Adult-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK AXL FRMPD1 PIPOX CSF1 CSPG4 CCL19	1.37e-06	176	139	7	56e19240f4a7b617a986e3c0854b757394e78251
ToppCell	3'-Adult-LymphNode-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK AXL FRMPD1 PIPOX CSF1 CSPG4 CCL19	1.37e-06	176	139	7	c88b46fe29ae7606c8880a6ff0ebb85c0dfda8bd
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-A AXL TMC6 RHBDD2 SIRPB1 FFAR4 SIGLEC1	1.48e-06	178	139	7	0b398656f26c4061b11ccf98908d0e2e1367585a
ToppCell	facs-Lung-nan-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL ADCY2 ADCY8 SLC2A4 SLC24A2 CSPG4 PLXNB1	1.54e-06	179	139	7	7078022e60faa86444f2a2c6eb9f767cc66b5cfa
ToppCell	facs-Lung-nan-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL ADCY2 ADCY8 SLC2A4 SLC24A2 CSPG4 PLXNB1	1.54e-06	179	139	7	d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AXL SIRPB1 SIRPA FFAR4 FCGR1A SIGLEC1 TNFAIP2	1.78e-06	183	139	7	103c4c4595d8daa677679fd2fa1e99cd398e56dd
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	COL7A1 SOBP PTPN13 CLCA2 PROM2 DHCR24 PLXNB1	2.06e-06	187	139	7	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	COVID-19-lung-Secretory\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CFTR SYBU MAL2 PTPN13 CLCA2 PROM2 DHCR24	2.45e-06	192	139	7	59261098ccb52306f837f632ebaea45b90ad30fe
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DMXL2 SIRPB1 SIRPA FFAR4 VCAN SIGLEC1 LILRB5	2.81e-06	196	139	7	5fe6534af65d43eeacd4b031310242b4f706008b
ToppCell	COVID-19_Moderate-Classical_Monocyte\|COVID-19_Moderate / disease group, cell group and cell class	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	2.90e-06	197	139	7	98d4107e457e7399a84439acd73bf8f59598971b
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.00e-06	198	139	7	d347462ba6cb1c5a59c86dffbbe914cbc1e9cf16
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.00e-06	198	139	7	c5a22846bccff948f90bc1d5fe309907dcd08348
ToppCell	COVID-19_Mild-Myeloid-Classical_Monocyte\|COVID-19_Mild / Disease group, lineage and cell class	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.00e-06	198	139	7	e78d027a095473af555762a4d542a73f5bb2e166
ToppCell	Monocytes-Phagocytic_CD16+_macrophages\|World / Immune cells in Kidney/Urine in Lupus Nephritis	DMXL2 ITSN1 SIRPB1 SIRPA VCAN SIGLEC1 TNFAIP2	3.00e-06	198	139	7	09009cc966bf1503c3b15dfa079a6c5f6ad1f507
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.00e-06	198	139	7	c49c71b34151d82b8795763bcb633c301c35f659
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.00e-06	198	139	7	4780f0276546962a2fc9f1041cfe49d2919d72b2
ToppCell	Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage\|Caecum / shred on region, Cell_type, and subtype	DMXL2 ADCY2 ASAP2 FCGR1A VCAN SIGLEC1 LILRB5	3.00e-06	198	139	7	e684c3934c163aef4d284b69435832d2c9614f2a
ToppCell	Caecum-Macrophage-LYVE1_Macrophage\|Caecum / Region, Cell class and subclass	DMXL2 ADCY2 ASAP2 FCGR1A VCAN SIGLEC1 LILRB5	3.00e-06	198	139	7	a92c0cacb775aca6bbb302bd9e22c081a112a44d
ToppCell	Biopsy_Other_PF-Epithelial-AT2\|Biopsy_Other_PF / Sample group, Lineage and Cell type	CFTR MAL2 PTPN13 HSD17B6 DHCR24 LRP2 SLC6A14	3.10e-06	199	139	7	9a65acfe9bf500db72142469cf17bf0973540001
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.10e-06	199	139	7	cd93e8947bcf3c2d7e6d5bfd70300145fba15f74
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Intermediate\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	CNTNAP3B CLEC18B ARHGAP17 SIRPA GRIN2C BTN3A2 RSPH1	3.10e-06	199	139	7	cf592d93612023a13de21e0fb8c6b13714f9af71
ToppCell	Bronchial-10x5prime-Epithelial-Epi_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFTR MAL2 PTPN13 HSD17B6 DHCR24 LRP2 SLC6A14	3.10e-06	199	139	7	a38a981cffa61c8444a980916de7414e689a1b63
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT2\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CFTR MAL2 PTPN13 HSD17B6 DHCR24 LRP2 SLC6A14	3.10e-06	199	139	7	fa5ddba3ac1ebe712cd4cdc3f20339f7c715d039
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DMXL2 HLA-A SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.10e-06	199	139	7	d2783e69da653184e38dc6d85b23521790fa24b8
ToppCell	distal-2-Epithelial-Alveolar_Epithelial_Type_2\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CFTR MAL2 PTPN13 HSD17B6 DHCR24 LRP2 SLC6A14	3.10e-06	199	139	7	21b44031bc5182ee23ba5e206042b2e5e4ee0c3c
ToppCell	Biopsy_IPF-Epithelial-AT2\|Biopsy_IPF / Sample group, Lineage and Cell type	C1orf167 MAL2 PTPN13 HSD17B6 DHCR24 LRP2 SLC6A14	3.10e-06	199	139	7	c841d475703d3489161fb7904526bd7563d5fb0f
ToppCell	COVID_vent-Myeloid\|COVID_vent / Disease condition, Lineage, Cell class and subclass	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.21e-06	200	139	7	621af09aae34226902c03edf556562f3ab35a7d8
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CLEC18B CLEC18C RFTN2 EXTL1 ADCY2 GHR CSPG4	3.21e-06	200	139	7	b5a54b9baf79aea01f76a161f0a39bbe87eb4945
ToppCell	Sigmoid-Macrophage-Macrophage\|Sigmoid / Region, Cell class and subclass	DMXL2 AXL SIRPA FCGR1A SIGLEC1 TNFAIP2 LILRB5	3.21e-06	200	139	7	9ee3a799de7bade1bfe94b6827461633f02bc1dc
ToppCell	Parenchyma_COVID-19-Epithelial-TX-AT2-1\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	CFTR MAL2 PTPN13 HSD17B6 DHCR24 LRP2 SLC6A14	3.21e-06	200	139	7	cf1991853e10c562edae9a0d71a209f35b07db80
ToppCell	COVID-19-COVID-19_Mild-Myeloid-CD14+_Monocyte\|COVID-19_Mild / Disease, condition lineage and cell class	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.21e-06	200	139	7	f76d3647f8ab5f7be018b0697c911597198e03f5
ToppCell	Sigmoid-(6)_Macrophage-(61)_LYVE1_Macrophage\|Sigmoid / shred on region, Cell_type, and subtype	DMXL2 ASAP2 FCGR1A VCAN SIGLEC1 TNFAIP2 LILRB5	3.21e-06	200	139	7	bc0280d52e4edc2c5edf4ead164a1c7cf3fccd60
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CLEC18B CLEC18C RFTN2 EXTL1 ADCY2 GHR CSPG4	3.21e-06	200	139	7	f5bd0b30e478dac09f68c46b0781f5f2e7e3c693
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT2\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFTR MAL2 PTPN13 HSD17B6 DHCR24 LRP2 SLC6A14	3.21e-06	200	139	7	23088edc62bf7d4db890937bfd7925dc316fcc76
ToppCell	COVID_vent-Myeloid-Monocytic-CD14+_Monocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.21e-06	200	139	7	e57452b73abb21cb3f645d45523ab93f6bef0243
ToppCell	COVID_non-vent-Myeloid-Monocytic-CD14+_Monocyte\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.21e-06	200	139	7	465ed50e0b92bb8c27ffe56d816f063a45b52be9
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFTR MAL2 PTPN13 HSD17B6 DHCR24 LRP2 SLC6A14	3.21e-06	200	139	7	b2d61bc3afac0d78aa30082760da5b1a15d1fad2
ToppCell	Sigmoid-(6)_Macrophage-(60)_Macrophage\|Sigmoid / shred on region, Cell_type, and subtype	DMXL2 AXL SIRPA FCGR1A SIGLEC1 TNFAIP2 LILRB5	3.21e-06	200	139	7	ad84a83a5a1893f7b053d39eddeca851463a8ff0
ToppCell	COVID_vent-Myeloid-Monocytic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.21e-06	200	139	7	b0a5bee87700ce38f26f95a6f491da7e27cade51
ToppCell	Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFTR MAL2 PTPN13 HSD17B6 DHCR24 LRP2 SLC6A14	3.21e-06	200	139	7	b535323e18d9fb0dde1e0026df142c831e48c29f
ToppCell	Sigmoid-Macrophage-LYVE1_Macrophage\|Sigmoid / Region, Cell class and subclass	DMXL2 ASAP2 FCGR1A VCAN SIGLEC1 TNFAIP2 LILRB5	3.21e-06	200	139	7	851a1b372ddbec522829069e69ed36a1f4832131
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Classical_Monocyte\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.21e-06	200	139	7	933db31e61e08ccf31105b3d3cf85c8d42c8174d
ToppCell	COVID_non-vent-Myeloid\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.21e-06	200	139	7	a40768e8e58c86b8e20bc188b9274ebe412fc765
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CFTR MAL2 PTPN13 HSD17B6 DHCR24 LRP2 SLC6A14	3.21e-06	200	139	7	7618ae284625c5c121bcc00eb9f07e5b1e3adf23
ToppCell	severe-CD163+_Monocytes_(Sample_ID1_d7)\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.21e-06	200	139	7	4943fe826d5fcc3dfeb8b99a7415848f3fecc994
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.21e-06	200	139	7	c1c6c379b00f63786a1bf9360b2ed1fc7142a3f0
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CFTR MAL2 PTPN13 HSD17B6 DHCR24 LRP2 SLC6A14	3.21e-06	200	139	7	23b319bf7e5ae03e5baa777c951da9bfc97cca8c
ToppCell	COVID_non-vent-Myeloid-Monocytic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.21e-06	200	139	7	4243a9d32f3a11141284d0d944cb81194b532876
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DMXL2 SIRPB1 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	3.21e-06	200	139	7	d47c7bb0af641a35562a95d55f98bbce70de7168
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFTR XBP1 PLAC4 ADCY2 CLCA2 VSIG10L2	8.35e-06	152	139	6	1b2a39ae159e79f1fb18d6d164bd7acab5299fca
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	XPNPEP2 LRRK1 GBGT1 TNFAIP2 PLIN1 TNXB	1.08e-05	159	139	6	cb2470b288c13e454a2a80115b0d5613b3f718e6
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DMXL2 AXL SIRPA SKOR1 SIGLEC1 TNFAIP2	1.20e-05	162	139	6	d712bc31840ad1523e3dbf884acbb428a8995001
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRADC1 SLITRK3 POMT1 SEMA4G APOBEC4 SLC7A3	1.24e-05	163	139	6	953a7db7e90a913e81002d2141fbbd5f1fdf2197
ToppCell	10x3'2.3-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TRIM58 AXL CSF1 IGSF9 SIGLEC1 LILRB5	1.24e-05	163	139	6	240d9f0ea45e8b2c7173e7674fd740555810f9e7
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRADC1 USP24 SLITRK3 SEMA4G SLC7A3 PLXNB1	1.24e-05	163	139	6	132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCell	343B-Epithelial_cells-Epithelial-A_(AT2)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	MAL2 PTPN13 DHCR24 LRP2 IGSF9 SLC6A14	1.29e-05	164	139	6	beaa13a75c3bb72446c85084d75e9fe3f15fd3d4
ToppCell	343B-Epithelial_cells-Epithelial-A_(AT2)\|343B / Donor, Lineage, Cell class and subclass (all cells)	MAL2 PTPN13 DHCR24 LRP2 IGSF9 SLC6A14	1.29e-05	164	139	6	d005cfd821b87548b075120bffe65a0be9860463
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Intermediate_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	DMXL2 SIRPA FCGR1A VCAN SIGLEC1 TNFAIP2	1.33e-05	165	139	6	c3fa9225d2f9c9e821d4fbd2315fcc98ce1f1c55
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DMXL2 SIRPA APOBEC4 FCGR1A VCAN TNFAIP2	1.38e-05	166	139	6	28a44448a0b0d72459e8fe84ce5d666f16f514b3
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	TRIM58 HIPK1 USP24 CHD4 RSPH1 PLXNB1	1.38e-05	166	139	6	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DMXL2 SIRPA APOBEC4 FCGR1A VCAN TNFAIP2	1.38e-05	166	139	6	2a04915d534a83e65aa168435d6856125b5bdd78
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK AXL CLCA2 CSPG4 HRC TNXB	1.43e-05	167	139	6	784776d1fcc098f84d3c2eca58fa56cb9428f434
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DMXL2 AXL SIRPA FFAR4 SIGLEC1 TNFAIP2	1.48e-05	168	139	6	a1755afa2cc50960ba60e07d84d61be429cdea72
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium-7\|TCGA-Endometrium / Sample_Type by Project: Shred V9	MYLK SLITRK3 SLC2A4 GHR HSD17B6 TNXB	1.48e-05	168	139	6	a97e8e07ba949b30805aeed5f60fa5e092b9d3d4
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DMXL2 SIRPA SLC24A2 VCAN SIGLEC1 TNFAIP2	1.58e-05	170	139	6	9ac1ef57f14418a5dd2aa16861c3df698c28f5ed
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	CNTNAP3 MAL2 HSD17B6 LRP2 IGSF9 CRB2	1.74e-05	173	139	6	3d7c281a1a9f183a5a861d1a9c7b50d216535893
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	CNTNAP3 MAL2 HSD17B6 LRP2 IGSF9 CRB2	1.74e-05	173	139	6	3aa90578371039f81b7c6fa873ec70f8f2bc7dfa
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DMXL2 AXL ENTHD1 SIRPA CDCA2 TNFAIP2	1.80e-05	174	139	6	65147b0f8c2ccadd5685430d31081520c157536a
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B HTR7 FRMPD1 CNTNAP3 ADCY8 TNFAIP2	1.92e-05	176	139	6	682a1dfcc507ec540f5fadf08e872533ea9f0291
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DMXL2 AXL SIRPA FFAR4 SIGLEC1 TNFAIP2	1.92e-05	176	139	6	e74ad0db3b05897edcfabeb11008ede2b9eeb638
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DMXL2 AXL SIRPA FFAR4 SIGLEC1 TNFAIP2	1.98e-05	177	139	6	71919b5c9bfa87fdd2cd44dfa057b66ea081be5d
ToppCell	390C-Epithelial_cells-Epithelial-B_(AT2)\|390C / Donor, Lineage, Cell class and subclass (all cells)	CFTR MAL2 PTPN13 DHCR24 LRP2 SLC6A14	2.11e-05	179	139	6	466da2bc3bfc534ffe111c8c28ece7a3cfa08051
ToppCell	390C-Epithelial_cells-Epithelial-B_(AT2)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	CFTR MAL2 PTPN13 DHCR24 LRP2 SLC6A14	2.11e-05	179	139	6	f4bdebb77d39e63160fbf3a85a340ce4d52b7cfd
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B HTR7 FRMPD1 CNTNAP3 ADCY8 TNFAIP2	2.11e-05	179	139	6	d1365d48d1b017a7917f4f63a82ac4720c3d87df
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	DMXL2 AXL ITSN1 SIGLEC1 TNFAIP2 LILRB5	2.18e-05	180	139	6	7be7d7a6906fff6dbdecd9cb013d855aba4eda2a
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLEKHG2 VCAN SIGLEC1 TNFAIP2 PLIN1 LILRB5	2.18e-05	180	139	6	66c7b02d85e32ba3e7530d0c4aff17e7525ccdd8
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B HTR7 FRMPD1 CNTNAP3 ADCY8 HRC	2.25e-05	181	139	6	bd7e9437839bca543ca5945df43d6525e6a312a8
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_1\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	GGT6 CFTR XBP1 MAL2 DHCR24 SLC6A14	2.25e-05	181	139	6	bab282cb0d9fc049f6fb094cf8b1fba104f4ea17
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL7A1 FRMPD1 ADCY8 SEMA4G CSPG4 PLXNB1	2.32e-05	182	139	6	9edaccf1154cec92ca9a28e9b1f9075cfd422bfd
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B HTR7 FRMPD1 CNTNAP3 ADCY8 TNFAIP2	2.32e-05	182	139	6	08aff7112c9dac0ef5540300516a604782b21169
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL7A1 FRMPD1 ADCY8 SEMA4G CSPG4 PLXNB1	2.32e-05	182	139	6	aba4c06d5d7618ac21b2695bca8e7a1346a91090
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFTR XBP1 SYBU ADCY2 CLCA2 PROM2	2.32e-05	182	139	6	3f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCell	droplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DMXL2 AXL SIRPA FFAR4 SIGLEC1 TNFAIP2	2.39e-05	183	139	6	ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f
ToppCell	Epithelial-lung_goblet_cell\|World / Lineage, Cell type, age group and donor	CFTR XBP1 SYBU ADCY2 CLCA2 PROM2	2.39e-05	183	139	6	940cbe298e9c53b5622af09264586ed823d3141f
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B HTR7 FRMPD1 CNTNAP3 ADCY8 GHR	2.39e-05	183	139	6	04d3cc76038b8192c915f1c08c3e26f2ad3b3779
ToppCell	(7)_Epithelial-H_(AT1)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	COL7A1 GGT6 ST6GALNAC2 CLCA2 PROM2 IGSF9	2.47e-05	184	139	6	1f76b37c265b519171b767a52d48f31f0cdc4a3c
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 NRCAM CFTR SLC24A2 LRP2 USH2A	2.47e-05	184	139	6	2cbed6462fea2622871bb7e49b0df3d984239281
Disease	level of tyrosine-protein phosphatase non-receptor type substrate 1 in blood serum	SIRPB1 SIRPA	1.93e-05	2	130	2	OBA_2040362
Disease	Endometrial Stromal Sarcoma	NUTM2A NUTM2B	1.91e-04	5	130	2	C0206630
Disease	Clear cell sarcoma of kidney	NUTM2E NUTM2B	2.86e-04	6	130	2	C0334488
Disease	osteopetrosis (implicated_via_orthology)	LRRK1 CSF1	3.99e-04	7	130	2	DOID:13533 (implicated_via_orthology)
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP3B CNTNAP3	5.30e-04	8	130	2	DOID:0060308 (implicated_via_orthology)
Disease	signal-regulatory protein beta-1 measurement	SIRPB1 SIRPA	6.80e-04	9	130	2	EFO_0802069
Disease	Familial thoracic aortic aneurysm and aortic dissection	MYLK VCAN MED12	1.67e-03	53	130	3	C4707243
Disease	Schizophrenia	HLA-A HTR7 PRSS16 XBP1 CHD4 SIRPB1 GRIN2C LRP2 HTR3B TNXB MED12	1.86e-03	883	130	11	C0036341
Disease	glycoprotein measurement	HLA-A PRSS16 POM121L2 LILRB5	1.93e-03	119	130	4	EFO_0004555
Disease	systemic lupus erythematosus, COVID-19	RFTN2 GBGT1 TNXB	2.16e-03	58	130	3	MONDO_0007915, MONDO_0100096
Disease	alcohol use disorder (is_implicated_in)	HTR7 HTR3B	2.22e-03	16	130	2	DOID:1574 (is_implicated_in)
Disease	respiratory symptom change measurement, response to placebo	ADCY8 CDCA2	2.51e-03	17	130	2	EFO_0008344, EFO_0010068
Disease	rheumatoid arthritis, COVID-19	GBGT1 CCL19 TNXB	2.86e-03	64	130	3	EFO_0000685, MONDO_0100096
Disease	Malignant neoplasm of breast	COL7A1 ATG10 NRCAM FRMPD1 XBP1 BTN3A2 CSF1 CLCA2 SURF1 ITSN2 MED12 PLXNB1	2.86e-03	1074	130	12	C0006142
Disease	lifestyle measurement, anxiety disorder measurement	RHBDD2 SIRPA GBGT1 USH2A	3.22e-03	137	130	4	EFO_0007795, EFO_0010724
Disease	autism spectrum disorder, schizophrenia	HLA-A PRSS16 POM121L2 ENTHD1 BTN3A2 TNXB	3.35e-03	327	130	6	EFO_0003756, MONDO_0005090
Disease	Malignant Glioma	MYLK HLA-A XBP1	3.69e-03	70	130	3	C0555198
Disease	dentures	BTN3A2 ADCY8 MED12	3.69e-03	70	130	3	EFO_0010078
Disease	dental caries, dentures	BTN3A2 ADCY8 MED12	3.69e-03	70	130	3	EFO_0003819, EFO_0010078
Disease	mixed gliomas	MYLK HLA-A XBP1	3.69e-03	70	130	3	C0259783

Protein segments in the cluster

Peptide	Gene	Start	Entry
PLPLTWAILAGLGTS	ADCY8	286	P40145
PTLPDTLQGSLLWAA	C1orf167	861	Q5SNV9
VLLLLPTQTWSPVGA	CNTNAP3	11	Q9BZ76
PDSTWILPISVGVIN	COX18	221	Q8N8Q8
ASLVVLWLLGNTPLQ	CFTR	876	P13569
QPWIAALAGTLPISL	BTN3A3	246	O00478
VTLIGNPWPDDLLST	VCAN	1601	P13611
SLTLELWAQGVPPAV	CSPG4	2141	Q6UVK1
SLASLWPRVVLSPIS	APOBEC4	176	Q8WW27
ISLPLSAIWAPDIII	HTR3B	106	O95264
WLISAVISFPPLVSL	ADRA2C	176	P18825
PLELVGSLLEQSAPW	GSDMD	401	P57764
LSQGPEEISLPLWAV	FAT4	4491	Q6V0I7
SWLSIVGPVVGLNLP	ATG10	191	Q9H0Y0
PSLPVSLSWVRDGIL	DMXL2	1246	Q8TDJ6
PAQWPGVSSLINLLS	DMXL2	2316	Q8TDJ6
ILSIPIWPPNLGISQ	ANGEL2	391	Q5VTE6
GPFLLVVPLSTLTSW	CHD1	531	O14646
LAVLGWLFQIPTVPE	CDAN1	746	Q8IWY9
SLPPEGNWTLVETLI	ARMCX5	241	Q6P1M9
GFITPLPEIAWISTL	OR6K2	151	Q8NGY2
AEFGWLLTSVLPTPV	RFTN2	366	Q52LD8
QSGLPAPVLAEIWAL	ITSN2	51	Q9NZM3
IWGPFLIISPASTLN	INO80	566	Q9ULG1
WSAPSNPLVIVVTGL	KIR2DL5A	106	Q8N109
LLSPILAGPSFWTLS	ENTHD1	436	Q8IYW4
PWTLSLTLTPSILTL	PLAC4	101	Q8WY50
TSSIPQLLVNLWGPE	OR2J1	76	Q9GZK6
SVRGTPVPRITWLLN	MYLK	536	Q15746
LSQPGVAIGLAWTPL	LONP2	651	Q86WA8
RISWLTNGVPIEIAP	NRCAM	391	Q92823
WLTTLITGLAGPLLI	ERVS71-1	571	P61550
ATLPSVIPWGLINLR	LRRK1	291	Q38SD2
LLWAPALSLLAGTVP	CRB2	21	Q5IJ48
SIPPGTLTTLWALSV	SLC2A4	71	P14672
ILLPSTWQQLPGVAL	HIPK1	756	Q86Z02
ALSLLVLWTSPAPTL	CCL19	6	Q99731
APDPTWLSTNLGILT	ASAP2	441	O43150
WSAPSNPLVIVVTGL	KIR2DL5B	106	Q8NHK3
ISICTLIWPTIPGEI	FFAR4	191	Q5NUL3
PILEWPGIQLTAVAV	PLXNB1	396	O43157
VLENVPPGTWLLTAT	PCDHGA9	251	Q9Y5G4
WLVAPLIAKLPTSVQ	MED12	1426	Q93074
WSNPSDLLEILVPGV	LILRB5	206	O75023
DVWVVSGPLTLPQTR	EXOG	191	Q9Y2C4
LLPVINTTLGWPNGL	LRP2	861	P98164
AQDLGLPIPSQWLAV	PGGHG	456	Q32M88
LPWAIISIPVNVTSI	PRADC1	161	Q9BSG0
ILSVPDLTPNIGLFW	PIGU	261	Q9H490
SFPVPTWILVLSLSL	HIDE1	111	A8MVS5
IPGVVPLSSLAQWGA	PLIN1	251	O60240
GLALWVLATQAPRLP	F2RL3	96	Q96RI0
SSNVPVWSLRLLPAL	POMT1	96	Q9Y6A1
GLVLAVLLQPGPSAW	GALR3	36	O60755
PWPRISLTIITTAII	ADCY2	676	Q08462
TLVQPELPTLSRLWL	HEATR5B	1471	Q9P2D3
WAPGRPFLTLVLLVS	GLP2R	46	O95838
LWGLVNNAGILTPIT	HSD17B6	106	O14756
PPTTWLGSLLLLVCL	CSF1	11	P09603
PTQLLTLTPWLAPIV	GBGT1	76	Q8N5D6
PPIALNWTLLNVSLT	GHR	151	P10912
LVTSLALLPGEWSPA	DBF4B	456	Q8NFT6
GPFLVSAPLSTIINW	CHD3	786	Q12873
LLVDPVTSIFLWPGN	FRMPD1	491	Q5SYB0
LTSIGWTLPVLPELD	DHCR24	146	Q15392
LPWPRLLVGPTTLAQ	GGT6	196	Q6P531
SGLPQPVLAQIWALA	ITSN1	51	Q15811
WTLVLLAIPPRIQPS	LINC01387	56	J3KSC0
LVLTLPGLPVWAQND	CBLN4	16	Q9NTU7
QPWIAALAGTLPILL	BTN3A2	246	P78410
VLSGAVLPLWSALPQ	CLPSL2	11	Q6UWE3
LRWELSSQPTIPIVG	HLA-A	296	P04439
WILVASSNVPLPLLQ	MAL2	51	Q969L2
ENEGLVWISLPLPST	CDCA2	901	Q69YH5
LELQVLGLQLPTPVW	FCGR1A	276	P12314
LRPVILGPTSILLSW	COL7A1	421	Q02388
LGPTSILLSWNLVPE	COL7A1	426	Q02388
PVPVTIALDSLSWLL	ELP5	116	Q8TE02
TQTLSLWAPTGVLLP	C1orf127	591	Q8N9H9
LWAPTGVLLPSLVEL	C1orf127	596	Q8N9H9
GPFLVSAPLSTIINW	CHD4	776	Q14839
LTLWGLFFPLNSIPT	SLC7A3	456	Q8WY07
VLLLLPTQTWSPVGA	CNTNAP3B	11	Q96NU0
LPAWIRIVLTEGTPT	FOCAD	1256	Q5VW36
NAAALLGLWVTPPLI	FOCAD	1441	Q5VW36
LGLWVTPPLIHSLSL	FOCAD	1446	Q5VW36
ISPWSLLLLPSGSVS	PTPN13	51	Q12923
ASAWLTALLLPIPAV	OR2AT4	151	A6NND4
VGVSIGTPLDPQWIL	MOXD2P	291	A6NHM9
TLVLTQAPLVWQAPG	NUTM2A	221	Q8IVF1
TLVLTQAPLVWQAPG	NUTM2B	221	A6NNL0
VLTQTPLVWQAPGAL	NUTM2D	151	Q5VT03
TLVLTQAPLVWQAPG	NUTM2E	221	B1AL46
ILTQAPLVWQAPGTL	NUTM2F	101	A1L443
ILTQAPLVWQAPGTL	NUTM2G	101	Q5VZR2
KLTWLTPLIPSTLLS	MT-ND2	236	P03891
LTTPLVNQWPSLGTL	RUNDC3A	336	Q59EK9
GLGQVTLRIWVSLPS	SKOR1	6	P84550
LLISWIPPEQSNGII	USH2A	4281	O75445
SNIFDITVGLPLPWL	SLC24A2	571	Q9UI40
PSNIAIVLGPNLLWA	ARHGAP17	396	Q68EM7
PVLVLAQWLPSLPTA	NBEAL2	451	Q6ZNJ1
STIALGWTTPIPLIE	SLITRK3	21	O94933
LSWNVVPNAGILPLV	SPCS3	146	P61009
LSIPVLLWGDLFTPA	ST6GALNAC2	86	Q9UJ37
TATSLIPVGPIQWFR	SIRPA	56	P78324
PSLGGLTRPVVLWSQ	SAMD10	106	Q9BYL1
SPLQNISPWILAVLT	XBP1	181	P17861
LLLIPVTAFGLGTWQ	SURF1	66	Q15526
ATQITELALWTPTLP	RSPH1	211	Q8WYR4
SVLWAGVASLLLPPA	HRC	11	P23327
SLLWNSPPGALLALS	EXTL1	381	Q92935
PETWLAIQPSLSLAL	POM121L2	376	Q96KW2
VTSLIPVGPIQWFRG	SIRPB1	56	Q5TFQ8
VWLLSASITLPPLFG	HTR7	206	P34969
PGSLTTLVPWAAALL	ATRAID	6	Q6UW56
FLVTWQASGPPEIIL	CLCA2	526	Q9UQC9
IPTPSLASGLWRTLQ	CLEC18B	91	Q6UXF7
IPTPSLASGLWRTLQ	CLEC18C	91	Q8NCF0
PPNLALVLLGALWTS	NDUFV1-DT	216	Q8NBR9
ATWLQPALPTLAEII	TNFAIP2	571	Q03169
WPLLLSILTATAVPG	SEMA4G	6	Q9NTN9
SWVLPLTGPLVSLLL	ERVFRD-1	481	P60508
PETLLSLWGLVSDVP	PROM2	191	Q8N271
LLAVAAPVVPTVLWA	SYBU	611	Q9NX95
GVQLLTPDSWNIPLT	SOBP	291	A7XYQ1
VVPSVLVPWLLLGAS	RHBDD2	161	Q6NTF9
WPLLLSAQENIAGIP	SRRM1	106	Q8IYB3
VTPTTLELGWLRPQA	TNXB	851	P22105
SAPVWLLSTLLATPV	VWCE	331	Q96DN2
LLWLQDAVPLATAPG	AXL	171	P30530
WAQGPLETVTLLPVA	SIGLEC1	751	Q9BZZ2
PSLVTWTQVSGLQPL	RPAP1	756	Q9BWH6
LQGSPVPSLRQSLLW	IGSF9	806	Q9P2J2
DGAPAQLPLVLTALW	ZDHHC24	11	Q6UX98
VLLAQVWLVPGLAPS	SERPINA10	11	Q9UK55
GVILTAQLPLWSPTS	USP24	1481	Q9UPU5
TLSLSPVRQDLLWPL	ZNF843	61	Q8N446
SVPLPVTWVLTAQGL	SNAPC4	1071	Q5SXM2
VTWVLTAQGLLPVPV	SNAPC4	1076	Q5SXM2
TAGPWTNQLLRPLGI	PIPOX	201	Q9P0Z9
LPLPQVLTDIWVQAL	PLEKHG2	1146	Q9H7P9
TLTWLGVLFSPLLPA	TMC6	601	Q7Z403
GTTPIVTWLLTEIPA	XPNPEP2	136	O43895
APLLVLWSFTPLGSL	VSIG10L2	61	P0DP72
SLGPVSVWRILPLFQ	SLC6A14	101	Q9UN76
PLLLVSLWGLLAPAS	PRSS16	11	Q9NQE7
LILPPTTIAGSGNWA	TRIM58	456	Q8NG06
TWVDIAPLLPTSLSV	UFL1	321	O94874
PPLWIGLFLVATGSQ	UNQ9165/PRO28630	16	Q6UXU0
LVSLPSWLLATPQAS	GARIN5B	716	Q8N5Q1
VWLVPNLALGSTDAP	GRIN2C	251	Q14957